-
Coating process: wood paint coating construction process
Time of Update: 2020-04-03
Classification of Waterborne Wood Coatings The color paint of water-based wood coatings mainly includes solid color paint and transparent color paint.
-
Fuchuang Pharmaceutical Group 1.1 fcn-411, a subsidiary of Fuxing Pharmaceutical Holding Co., Ltd., obtained clinical approval
Time of Update: 2020-04-03
Announcement of Shanghai Fosun Pharmaceutical (Group) Co., Ltd
on the approval of holding subsidiaries for drug clinical trials the board of directors and all directors
-
Intervention without implantation! Xinzhi medical innovative research and development of coronary drug balloon can effectively solve the pain points of traditional stent surgery
Time of Update: 2020-02-13
In 2016, Sheng Weiwen, who has been engaged in the research and development of cardiovascular products in domestic famous enterprises, found a new treatment scheme for coronary intervention - drug balloon market opportunity.
-
In 2020, the pharmaceutical retail industry ushered in a great change
Time of Update: 2020-02-12
[pharmaceutical network market analysis] with the strengthening of national supervision on the pharmaceutical industry, new policies emerge frequently in the pharmaceutical
-
The products of 29 pharmaceutical companies "going abroad" are bright and bright
Time of Update: 2020-01-19
Pantoprazole sodium for injection is the first anda approved by Huadong Pharmaceutical Co., Ltd. at present, there is no product evaluation of other enterprises in the domestic market.
-
29 pharmaceutical enterprises' products "going out of the country" Fuxing and dongyangguang show outstanding performance
Time of Update: 2020-01-19
Under a series of policies, R & D innovation and internationalization have become the main direction of the development of pharmaceutical enterprises
According
-
2020 Internet hospitals will break the 100 billion mark, but there are three major problems to be solved
Time of Update: 2020-01-08
The 2020 China Internet Hospital Development Research Report deeply analyzes the current construction progress, existing problems, future construction development trend and typical
-
Sorting out the key points of the second batch of national volume procurement (with colored eggs
Time of Update: 2019-12-31
2. The three requirements of quotation should bear in mind that in fact, the so-called shortlist of volume purchase is only the second pass of "qualification" acquisition.
-
The top list of clinical trial applicants is Zhengda Tianqing and Hengrui
Time of Update: 2019-11-08
In October, 59 clinical trials of be were registered, 27 of which were consistency evaluation trials; The hottest registered varieties in October were rivaroxaban tablets
-
Top list of clinical trial applicants, Zhengda Tianqing, Hengrui
Time of Update: 2019-11-08
In October, 59 clinical trials of chemical be were registered, 27 of which were consistency evaluation clinical trials; the hottest registered varieties in October were rivaroxaban
-
Three arrows in a row to reform drug regulation
Time of Update: 2019-10-24
The drug administration law, which was deliberated and adopted at the 12th session of the 13th National People's Congress in August this year, will come into force on December 1
-
For those who pass the consistency evaluation but fail to win the bid under the restriction, Jiangxi province will implement direct online procurement
Time of Update: 2019-08-08
On August 8, Jiangxi provincial drug centralized purchase network published the notice on direct online purchase of anti-cancer drugs that failed to win the bid through
-
Chongqing is not only magic, but also it! ——The iterative version of pharmaceutical intelligence data app goes online
Time of Update: 2019-07-08
In the registration and acceptance database, the subscription push function is added this time, that is, data subscription is carried out through acceptance number, drug name, enterprise name, Chinese active ingredient, etc.
-
The release of new book "big data of China's pharmaceutical R & D in the past 40 years
Time of Update: 2019-07-01
New book release of China Pharmaceutical R & D 40 years big data interpretation industry 40 years storm purchase consultation: Zhang Jiaqing, mobile phone: 15123085574 (same
-
Guidelines for evaluation of clinical safety literature of listed drugs issued by SFDA
Time of Update: 2019-06-19
On June 18, the State Food and Drug Administration issued a circular on the guiding principles for clinical safety literature evaluation of listed drugs (Trial).
-
The 19th batch of Jiangxi centralized procurement audit list has been issued
Time of Update: 2019-06-04
See the chart for specific contents: the list of specific drugs is as follows: This article is the content reprinted by yaozhi.com, and the copyright belongs to the original author.
-
Pharmaceutical intelligence data app2.3 iteration Online
Time of Update: 2019-05-21
After one month's precipitation, pharmaceutical intelligence app2.3 was successfully launched online
The updated version of small partners may be surprised to find
-
The standard of traditional Chinese medicine of Hebei Province was officially released and implemented on June 1
Time of Update: 2019-04-25
In order to further strengthen the quality management of traditional Chinese medicine and herbal pieces, ensure the safety and effectiveness of people's drug use, and promote
-
After the cancellation of the 2018 deadline, the official draft of the reference preparation came
Time of Update: 2019-03-29
After the cancellation of the 2018 deadline, the official draft of the reference preparation finally came! On March 28, the State Food and Drug Administration issued
-
[heavyweight] after the 2018 deadline was cancelled, the official draft of the reference preparation finally came
Time of Update: 2019-03-29
After the cancellation of the 2018 deadline, the official draft of the reference preparation finally came! On March 28, the State Food and Drug Administration issued
